Furthermore, Mettl3 SUMOylation has been preliminary identified to enhance tumor growth in human non-small cell lung carcinoma cell line H1299 24, but the role of Mettl3 SUMOylation in liver cancer progression and the underlying regulatory mechanisms of tumorigenesis have yet to be elucidated. The gene discussed is METTL3; the disease is liver cancer.